Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate
Tianjin Tianyao Pharmaceuticals Co Ltd cash flow reinvestment rate. Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Cash Flow Reinvestment Rate of 1.33x as of September 2025, reinvesting CN¥17.49 Million (capex CN¥17.49 Million ) from operating cash flow of CN¥13.19 Million. Explore 600488 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Cash flow reinvestment rate of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. Historical reinvestment intensity for Tianjin Tianyao Pharmaceuticals Co Ltd across 23 annual periods. Explore 600488 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate by Year (2000–2024)
Tianjin Tianyao Pharmaceuticals Co Ltd cash flow reinvestment rate by year from 2000 to 2024. Year-by-year capital reinvestment analysis for Tianjin Tianyao Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Tianjin Tianyao Pharmaceuticals Co Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥153.93 Million | CN¥569.37 Million | CN¥77.74 Million | ▲ +59.0% |
| 2023 | 0.17x | CN¥133.15 Million | CN¥783.01 Million | CN¥133.15 Million | ▼ -72.2% |
| 2022 | 0.61x | CN¥400.33 Million | CN¥653.52 Million | CN¥202.20 Million | ▼ -74.0% |
| 2021 | 2.36x | CN¥747.80 Million | CN¥316.89 Million | CN¥370.84 Million | ▼ -21.5% |
| 2020 | 3.01x | CN¥1.04 Billion | CN¥346.88 Million | CN¥458.51 Million | ▲ +200.2% |
| 2019 | 1.00x | CN¥279.74 Million | CN¥279.37 Million | CN¥279.04 Million | ▼ -7.0% |
| 2018 | 1.08x | CN¥203.88 Million | CN¥189.27 Million | CN¥203.58 Million | ▼ -68.2% |
| 2016 | 3.39x | CN¥214.78 Million | CN¥63.32 Million | CN¥64.78 Million | ▲ +125.9% |
| 2015 | 1.50x | CN¥194.48 Million | CN¥129.50 Million | CN¥45.32 Million | ▲ +1499.9% |
| 2014 | 0.09x | CN¥16.78 Million | CN¥178.76 Million | CN¥16.78 Million | ▼ -97.4% |
| 2013 | 3.67x | CN¥310.08 Million | CN¥84.55 Million | CN¥310.08 Million | ▼ -35.8% |
| 2012 | 5.71x | CN¥75.59 Million | CN¥13.23 Million | CN¥75.59 Million | ▲ +614.5% |
| 2011 | 0.80x | CN¥62.76 Million | CN¥78.47 Million | CN¥62.76 Million | ▼ -36.8% |
| 2010 | 1.26x | CN¥147.76 Million | CN¥116.82 Million | CN¥147.76 Million | ▲ +172.0% |
| 2009 | 0.46x | CN¥202.32 Million | CN¥435.13 Million | CN¥202.32 Million | ▼ -71.5% |
| 2008 | 1.63x | CN¥357.63 Million | CN¥219.31 Million | CN¥357.63 Million | ▲ +17.8% |
| 2007 | 1.38x | CN¥224.74 Million | CN¥162.33 Million | CN¥224.74 Million | ▼ -1.0% |
| 2006 | 1.40x | CN¥70.91 Million | CN¥50.72 Million | CN¥70.91 Million | ▲ +15.5% |
| 2004 | 1.21x | CN¥133.47 Million | CN¥110.30 Million | CN¥133.47 Million | ▼ -68.2% |
| 2003 | 3.81x | CN¥174.24 Million | CN¥45.77 Million | CN¥174.24 Million | ▲ +0.7% |
| 2002 | 3.78x | CN¥171.20 Million | CN¥45.28 Million | CN¥171.20 Million | ▲ +459.5% |
| 2001 | 0.68x | CN¥48.57 Million | CN¥71.87 Million | CN¥48.57 Million | ▼ -23.5% |
| 2000 | 0.88x | CN¥36.29 Million | CN¥41.06 Million | CN¥36.29 Million | — |